Vimarsana
Biggest News Aggregation in the World

Page 30 - Quantitative Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quantitative Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quantitative Research Today - Breaking & Trending Today

Market at record high again! 4 of top experts list out sectors to pick and avoid - Vimarsana News

Market at record high again! 4 of top experts list out sectors to pick and avoid

The Sensex rose over 720 points to its new high of 71,234.63, whereas the broader Nifty50 index advanced 214.4 points to its record high of 21,397.10.

Adani Power, Jio Financial, IRFC, PFC shares likely to enter Nifty Next 50 index, says Nuvama - Vimarsana News

Adani Power, Jio Financial, IRFC, PFC shares likely to enter Nifty Next 50 index, says Nuvama

If Jio Financial is included, the stock could see $66 million in passive inflows. IRFC ($15 million inflows), PFC ($45 million inflows), Polycab India ($20 million inflows, Adani Power ($33 million inflows) are other likely Nifty Next 50 entrants.

BHEL, PNB among likely MSCI inclusion candidates; Nykaa, Union Bank stocks in focus - Vimarsana News

BHEL, PNB among likely MSCI inclusion candidates; Nykaa, Union Bank stocks in focus

Bharat Heavy Electricals Ltd, Punjab National Bank Ltd, Oberoi Realty and Jindal Stainless Ltd would be required to broadly maintain their prevailing price levels to enter MSCI Global Standard Index in the February review.

Health costs grew in line with overall inflation in 2023, new Turquoise data shows - Vimarsana News

Health costs grew in line with overall inflation in 2023, new Turquoise data shows

Healthcare

Mankind Pharma block deal: 8.7% equity worth Rs 6,395 cr changes hands as 3 PE funds likely sellers - Vimarsana News

Mankind Pharma block deal: 8.7% equity worth Rs 6,395 cr changes hands as 3 PE funds likely sellers

Moneycontrol had reported citing sources that three private equity funds- Chrys Capital, Capital Group and Everbridge Partners, were looking to pare stake in Mankind Pharma worth at least $592 million through block deals.